Boji Medical’s Huasheng Transfers Glucosamine Sulfate Capsules Technology to Panlong
On March 20, 2025, Boji Medical Technology Co., Ltd (known as Boji Biomedicals) (SHE: 300404)...
Deals
Oxford BioTherapeutics Partners with Roche on Cancer Therapeutics Discovery
On March 19, 2025, Oxford BioTherapeutics announced a multiyear collaboration with Roche (SWX: ROG, OTCMKTS:...
Servier and Black Diamond Therapeutics Ink Global Deal for BDTX-4933
French pharmaceutical company Servier and US-based Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) announced a strategic...
Distinct Healthcare Files for Hong Kong IPO to Expand Integrated Medical Services
Shenzhen-based Distinct Healthcare Holdings Limited, a comprehensive medical service provider with integrated online and offline...
GE Healthcare and NVIDIA Expand Partnership to Advance Autonomous X-ray and Ultrasound Technologies
US medical device and life sciences giant GE Healthcare Technologies Inc. (NASDAQ: GEHC) announced an...
Formosa Pharmaceuticals Inks Licensing Pact with Cipla for APP13007 in 11 Countries
Taiwan-based Formosa Pharmaceuticals (TPE: 6838) announced a licensing agreement with India-headquartered Cipla Limited (BOM: 500087,...
Eisai Launches JPY16 Billion Tender for EcoNaviSta to Expand Dementia Care Ecosystem
Japan-based Eisai Co., Ltd (TYO: 4523) announced a tender offer valued at JPY16 billion (USD107...
Taiho Pharmaceutical to Acquire Araris Biotech for USD 400 Million, Expanding ADC Portfolio
Japan-based Taiho Pharmaceutical Co., Ltd. announced plans to fully acquire Araris Biotech AG, a Swiss...
PomDoctor Files for Nasdaq IPO to Expand Chronic Disease Management Services
Guangzhou-based PomDoctor Limited, a leading online medical services platform for chronic disease management, has filed...
AstraZeneca to Acquire EsoBiotec for Up to $1 Billion to Boost Cell Therapy Portfolio
On March 17, 2025, EsoBiotec SA announced a definitive acquisition agreement with AstraZeneca (NASDAQ: AZN)....
AstraZeneca Licenses Alteogen’s ALT-B4 for Subcutaneous Cancer Therapies
UK-based pharmaceutical giant AstraZeneca (NASDAQ: AZN) has entered into a licensing agreement with South Korea-headquartered...
Basilea Pharmaceutica Marks Milestone as Cresemba Sales Soar in Asia Pacific
Switzerland-based Basilea Pharmaceutica Ltd (SWX: BSLN) announced that its antifungal Cresemba (isavuconazole), commercialized by Pfizer...
Accropeutics Closes RMB100 Million Series B+ Round to Advance Inflammatory Disease Pipeline
Accropeutics Inc., a clinical-stage biotech company with operations in New York, US, and Suzhou, China,...
Pharmavan and Kefeng Changjian Sign Pact to Accelerate SPT-07A Development
Suzhou Pharmavan Co., Ltd. has announced plans to enter into a cooperation agreement with Sichuan...
Quantum Hi-Tech and ECNU Establish AI-Driven Drug Manufacturing Lab
CRO+CDMO Quantum Hi-Tech (China) Biotechnology Co., Ltd (ChemPartner, SHE: 300149) announced plans to establish an...
BioCity and MSD Enter Clinical Collaboration for BC3195 and Keytruda Combination Trial
China-based BioCity Biopharmaceutics Co., Ltd. announced a clinical collaboration agreement with US-based giant Merck, Sharp...
Shanghai Fosun Pharmaceutical Transfers Unicorn II Holdings Stake to Warburg Pincus Subsidiary
China-based Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) announced plans to transfer...
Salipro Biotech and Boehringer Ingelheim Collaborate on Drug Development for Membrane Proteins
Sweden-based Salipro Biotech AB announced a research and license agreement with German pharmaceutical giant Boehringer...
Insilico Medicine Closes USD110 Million Series E Round to Advance AI-Driven Drug Pipeline
China’s generative artificial intelligence (AI)-driven biotech Insilico Medicine announced the completion of a USD110 million...
Sanyou Medical Raises RMB214 Million for Stake in SMTP Technology
China-based Shanghai Sanyou Medical Co., Ltd (SHA: 688085) announced the completion of a private placement...